
Eric Marsh
Clinical Director, Penn Orphan Disease Center · Children's Hospital of Philadelphia
Credentials: · · · ·
History
- Present
Penn Orphan Disease Center · Children's Hospital of Philadelphia
- Present
Orphan Disease Center · University of Pennsylvania Health System
- 2005–2009
1998–1999Physiology and Neuroscience - New York University- Sackler School of Biomedical Sciences, New York, NY

Research
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
New England Journal of Medicine · 2017 · 1,120 citations
The Lancet · 2018 · 640 citations
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
The Lancet Neurology · 2016 · 639 citations

58 papers

40 papers

39 papers

24 papers

21 papers

19 papers
- DL
18 papers
- HO
18 papers
Grants
- 1998–2028
Training Program in Neurodevelopmental Disabilities
National Institute of Neurological Disorders and Stroke · T32
PI · $1.9M · Children's Hosp of Philadelphia
- 2023–2028
National Institute of Neurological Disorders and Stroke · R33
Contact PI · $811K · Children's Hosp of Philadelphia
- 2021–2027
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn
National Institute of Child Health and Human Development · P50
PI · $6.7M · Children's Hosp of Philadelphia
- 2021–2027
National Institute of Neurological Disorders and Stroke · U01
PI · $4.7M · University of Colorado Denver
Clinical trials
- 2023–2029
Neurophysiologic Biomarkers in Rett Syndrome
Principal investigator · Recruiting
Children's Hospital of Philadelphia
- 2017–2021
Rare Diseases Clinical Research Network: Neurophysiological Correlates
Principal investigator · Completed
University of Alabama at Birmingham
- 2016–2017
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
Principal investigator · Completed · Phase 2
Neuren Pharmaceuticals Limited
- 2021–2027

